1
|
Fernández-Bertólez N, Costa C, Brandão F, Teixeira JP, Pásaro E, Valdiglesias V, Laffon B. Toxicological Aspects of Iron Oxide Nanoparticles. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2022; 1357:303-350. [DOI: 10.1007/978-3-030-88071-2_13] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
2
|
Stimuli responsive and receptor targeted iron oxide based nanoplatforms for multimodal therapy and imaging of cancer: Conjugation chemistry and alternative therapeutic strategies. J Control Release 2021; 333:188-245. [DOI: 10.1016/j.jconrel.2021.03.021] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 03/17/2021] [Accepted: 03/17/2021] [Indexed: 12/18/2022]
|
3
|
Mossoba ME, Mapa MST, Sprando J, Araujo M, Sprando RL. Evaluation of transporter expression in HK-2 cells after exposure to free and ester-bound 3-MCPD. Toxicol Rep 2021; 8:436-442. [PMID: 33717996 PMCID: PMC7932896 DOI: 10.1016/j.toxrep.2021.02.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Revised: 02/18/2021] [Accepted: 02/20/2021] [Indexed: 12/22/2022] Open
Abstract
3-Monochloropropane-1,2-diol (3-MCPD) and its fatty acid esters have the potential to induce nephrotoxicity. We used an in vitro cellular model of human proximal tubule cells to test the effects of 3-MCPD compound exposures on transporter gene expression. 3-MCPD-related nephrotoxicity could be associated with indirect modes of action relating to aquaporin homeostasis.
3-Monochloropropane-1,2-diol (3-MCPD) is a food processing contaminant in some infant formula products and other foods in the United States. Although rodent studies have demonstrated that 3-MCPD and its palmitic esters have the potential to induce nephrotoxicity, our recent human cell culture studies using the human renal proximal tubule cell line HK-2 have not strongly supported this finding. Considering this disparity, we sought to examine whether changes in transporter gene expression on proximal tubule cells could be modulated by these compounds and allow us to glean mechanistic information on a possible indirect path to proximal tubule injury in vivo. If fundamental processes like water and solute transport could be disrupted by 3-MCPD compounds, then a new avenue of toxicity could be further explored in both infant and adult models. In our current study, we used HK-2 cells as an in vitro cellular model of human proximal tubule cells to investigate the effects of low (10 μM) and high (100 μM) 3-MCPD compound exposures to these cells for 24 hours (h) on the expression of 20 transporter genes that are known to be relevant to proximal tubules. Although we detected consistent upregulation of AQP1 expression at the RNA transcript level following HK-2 treatment with both low and high doses of several ester-bound 3-MCPD compounds, these increases were not associated with statistically significant elevations in their protein expression levels. Moreover, we observed a lack of modulation of other members of the AQP protein family that are known to be expressed by human proximal tubule cells. Overall, our study suggests the possibility that 3-MCPD-related nephrotoxicity could be associated with indirect modes of action relating to aquaporin homeostasis, but additional studies with other human-derived models would be pertinent to further explore these findings and to better understand transporter expression differences under different stages of proximal tubule development.
Collapse
Key Words
- 1-Li, 1-Linoleoyl-3-chloropropanediol
- 1-Ol, 1-Oleoyl-3-chloropropanediol
- 1-Pa, 1-Palmitoyl-3-chloropropanediol
- 3-MCPD, 3-Monochloropropane-1,2-diol
- 3-Monochloropropane-1,2-diol
- HK-2
- HK-2, Human Kidney-2
- Kidney
- Li, Linoleic Acid
- Li-Li, 1,2-Di-linoleoyl-3-chloropropanediol
- Ol, Oleic Acid
- Ol-Li, 1-Oleoyl-2-linoleoyl-3-chloropropanediol
- Ol-Ol, 1,2-Di-oleoyl-3-chloropropanediol
- PMA, Phenylmercuric Acetate
- Pa, Palmitic Acid
- Pa-Li, 1-Palmitoyl-2-linoleoyl-3-chloropropanediol
- Pa-Ol, 1-Palmitoyl-2-oleoyl-3-chloropropanediol
- Pa-Pa, 1,2-Di-palmitoyl-3-chloropropanediol
- VAL, Valproic Acid
Collapse
Affiliation(s)
- Miriam E Mossoba
- U.S. Food and Drug Administration (U.S. FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DT), Laurel, MD, 20817, United States
| | - Mapa S T Mapa
- U.S. Food and Drug Administration (U.S. FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DT), Laurel, MD, 20817, United States
| | - Jessica Sprando
- Virginia-Maryland College of Veterinary Medicine, 205 Duck Pond Road, Blacksburg, VA, 24061, United States
| | - Magali Araujo
- U.S. Food and Drug Administration (U.S. FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DT), Laurel, MD, 20817, United States
| | - Robert L Sprando
- U.S. Food and Drug Administration (U.S. FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DT), Laurel, MD, 20817, United States
| |
Collapse
|
4
|
Carvalho AM, Cordeiro RA, Faneca H. Silica-Based Gene Delivery Systems: From Design to Therapeutic Applications. Pharmaceutics 2020; 12:E649. [PMID: 32660110 PMCID: PMC7407166 DOI: 10.3390/pharmaceutics12070649] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Revised: 07/07/2020] [Accepted: 07/08/2020] [Indexed: 12/11/2022] Open
Abstract
Advances in gene therapy have been foreshadowing its potential for the treatment of a vast range of diseases involving genetic malfunctioning. However, its therapeutic efficiency and successful outcome are highly dependent on the development of the ideal gene delivery system. On that matter, silica-based vectors have diverted some attention from viral and other types of non-viral vectors due to their increased safety, easily modifiable structure and surface, high stability, and cost-effectiveness. The versatility of silane chemistry and the combination of silica with other materials, such as polymers, lipids, or inorganic particles, has resulted in the development of carriers with great loading capacities, ability to effectively protect and bind genetic material, targeted delivery, and stimuli-responsive release of cargos. Promising results have been obtained both in vitro and in vivo using these nanosystems as multifunctional platforms in different potential therapeutic areas, such as cancer or brain therapies, sometimes combined with imaging functions. Herein, the current advances in silica-based systems designed for gene therapy are reviewed, including their main properties, fabrication methods, surface modifications, and potential therapeutic applications.
Collapse
Affiliation(s)
| | | | - Henrique Faneca
- Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal; (A.M.C.); (R.A.C.)
| |
Collapse
|
5
|
Gold Nanoparticles Induce Oxidative Stress and Apoptosis in Human Kidney Cells. NANOMATERIALS 2020; 10:nano10050995. [PMID: 32455923 PMCID: PMC7279525 DOI: 10.3390/nano10050995] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Revised: 05/14/2020] [Accepted: 05/16/2020] [Indexed: 12/15/2022]
Abstract
Gold nanoparticles (AuNPs) are highly attractive for biomedical applications. Therefore, several in vitro and in vivo studies have addressed their safety evaluation. Nevertheless, there is a lack of knowledge regarding their potential detrimental effect on human kidney. To evaluate this effect, AuNPs with different sizes (13 nm and 60 nm), shapes (spheres and stars), and coated with 11-mercaptoundecanoic acid (MUA) or with sodium citrate, were synthesized, characterized, and their toxicological effects evaluated 24 h after incubation with a proximal tubular cell line derived from normal human kidney (HK-2). After exposure, viability was assessed by the MTT assay. Changes in lysosomal integrity, mitochondrial membrane potential (ΔΨm), reactive species (ROS/RNS), intracellular glutathione (total GSH), and ATP were also evaluated. Apoptosis was investigated through the evaluation of the activity of caspases 3, 8 and 9. Overall, the tested AuNPs targeted mainly the mitochondria in a concentration-dependent manner. The lysosomal integrity was also affected but to a lower extent. The smaller 13 nm nanospheres (both citrate- and MUA-coated) proved to be the most toxic among all types of AuNPs, increasing ROS production and decreasing mitochondrial membrane potential (p ≤ 0.01). For the MUA-coated 13 nm nanospheres, these effects were associated also to increased levels of total glutathione (p ≤ 0.01) and enhanced ATP production (p ≤ 0.05). Programmed cell death was detected through the activation of both extrinsic and intrinsic pathways (caspase 8 and 9) (p ≤ 0.05). We found that the larger 60 nm AuNPs, both nanospheres and nanostars, are apparently less toxic than their smaller counter parts. Considering the results herein presented, it should be taken into consideration that even if renal clearance of the AuNPs is desirable, since it would prevent accumulation and detrimental effects in other organs, a possible intracellular accumulation of AuNPs in kidneys can induce cell damage and later compromise kidney function.
Collapse
|
6
|
Královec K, Havelek R, Koutová D, Veverka P, Kubíčková L, Brázda P, Kohout J, Herynek V, Vosmanská M, Kaman O. Magnetic nanoparticles of Ga-substituted ε-Fe 2 O 3 for biomedical applications: Magnetic properties, transverse relaxivity, and effects of silica-coated particles on cytoskeletal networks. J Biomed Mater Res A 2020; 108:1563-1578. [PMID: 32176405 DOI: 10.1002/jbm.a.36926] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2020] [Accepted: 03/12/2020] [Indexed: 12/15/2022]
Abstract
Magnetic nanoparticles of ε-Fe1.76 Ga0.24 O3 with the volume-weighted mean size of 17 nm were prepared by thermal treatment of a mesoporous silica template impregnated with metal nitrates and were coated with silica shell of four different thicknesses in the range 6-24 nm. The bare particles exhibited higher magnetization than the undoped compound, 22.4 Am2 kg-1 at 300 K, and were characterized by blocked state with the coercivity of 1.2 T at 300 K, being thus the very opposite of superparamagnetic iron oxides. The relaxometric study of the silica-coated samples at 0.47 T revealed promising properties for MRI, specifically, transverse relaxivity of 89-168 s-1 mmol(f.u.)-1 L depending on the shell thickness was observed. We investigated the effects of the silica-coated nanoparticles on human A549 and MCF-7 cells. Cell viability, proliferation, cell cycle distribution, and the arrangement of actin cytoskeleton were assessed, as well as formation and maturation of focal adhesions. Our study revealed that high concentrations of silica-coated particles with larger shell thicknesses of 16-24 nm interfere with the actin cytoskeletal networks, inducing thus morphological changes. Consequently, the focal adhesion areas were significantly decreased, resulting in impaired cell adhesion.
Collapse
Affiliation(s)
- Karel Královec
- Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic
| | - Radim Havelek
- Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
| | - Darja Koutová
- Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
| | - Pavel Veverka
- Institute of Physics, Czech Academy of Sciences, Praha, Czech Republic
| | - Lenka Kubíčková
- Institute of Physics, Czech Academy of Sciences, Praha, Czech Republic.,Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - Petr Brázda
- Institute of Physics, Czech Academy of Sciences, Praha, Czech Republic
| | - Jaroslav Kohout
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - Vít Herynek
- First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Magda Vosmanská
- Faculty of Chemical Engineering, University of Chemistry and Technology, Praha, Czech Republic
| | - Ondřej Kaman
- Institute of Physics, Czech Academy of Sciences, Praha, Czech Republic
| |
Collapse
|